Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Incyte
Incyte
Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD
Fierce Pharma
Tue, 06/8/21 - 09:42 pm
Incyte
FDA
JAK inhibitors
ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca
BioSpace
Thu, 05/20/21 - 12:35 pm
ASCO 2021
Sanofi
Sloane Kettering
Incyte
AstraZeneca
Exelixis
oncology
Incyte’s Ruxolitinib Cream Shows Promise for Vitiligo in Phase III Trials Published: May 17, 2021 By Brandon May
BioSpace
Mon, 05/17/21 - 11:02 pm
Incyte
ruxolitinib
vitiligo
clinical trials
Incyte’s PD-(L)1 inhibitor headed for an ODAC showdown next month
Endpoints
Thu, 05/13/21 - 12:06 pm
Incyte
FDA
ODAC
anal cancer
retifanlimab
Incyte to pay $12.6 million to resolve drug charity kickback claims
Reuters
Fri, 05/7/21 - 10:54 am
Incyte
Jakafi
kickbacks
Medicare
Lilly claims promising finding in failed study of COVID-19 drug
BioPharma Dive
Thu, 04/8/21 - 07:40 pm
Eli Lilly
Incyte
COVID-19
baricitinib
Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial
TheStreet.com
Sun, 03/21/21 - 11:57 pm
Incyte
Jakafi
clinical trials
COVID-19
ARDS
Jakafi failed the primary endpoint in a Covid-19 study. But Incyte is still going to FDA with a compassionate use pitch
Endpoints
Fri, 03/19/21 - 10:49 am
Jakafi
Incyte
COVID-19
clinical trials
Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment
NASDAQ
Wed, 03/3/21 - 10:53 am
Eli Lilly
Incyte
baricitinib
alopecia areata
FDA to quickly review Incyte’s Jakafi in chronic GVHD
Pharmaforum
Tue, 02/23/21 - 10:42 am
FDA
Incyte
Jakafi
graft vs host disease
Incyte Says FDA Grants Priority Review For Eczema Cream
Yahoo/SmarterAnalyst
Mon, 02/22/21 - 11:00 am
Incyte
eczema
FDA
priority review
ruxolitinib
What's Behind Incyte's Better-Than-Expected Q4 Earnings
Motley Fool
Tue, 02/9/21 - 11:57 pm
Incyte
earnings
Incyte makes bid to join the checkpoint inhibitor club
Pharmaforum
Tue, 02/2/21 - 10:25 am
Incyte
FDA
retifanlimab
anal cancer
HIV
HPV
Incyte lands priority review for PD-1 inhibitor in anal cancer
Fierce Biotech
Fri, 01/22/21 - 10:31 am
Incyte
FDA
priority review
anal cancer
retifanlimab
JPM: Established relationships were key to pandemic drug launches, Incyte CEO says
Fierce Pharma
Sat, 01/16/21 - 11:48 pm
COVID-19
pandemic
drug launches
Incyte
JPMHC 2021
Novartis/Incyte draw blank with Jakafi in COVID-19
Pharmaforum
Mon, 12/14/20 - 10:35 am
Novartis
Incyte
Jakafi
COVID-19
clinical trials
EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Yahoo
Sun, 11/1/20 - 01:37 pm
Eli Lilly
Incyte
baricitinib
atopic dermatitis
EADV
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
Marketwatch
Mon, 09/14/20 - 10:21 am
Eli Lilly
Incyte
olumiant
COVID-19
remdesivir
Gilead Sciences
Karuna and Incyte scrap programs; More cash for the SPACs
Endpoints
Wed, 08/5/20 - 12:02 am
Karuna Therapeutics
Eli Lilly
Incyte
SPAC
FDA approves MorphoSys, Incyte’s drug for vulnerable lymphoma population
MedCity News
Mon, 08/3/20 - 10:14 am
FDA
Monjuvi
CAR-T
MorphoSys
Incyte
diffuse large B-cell lymphoma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »